FCLAX (FCLAX) Stock Price & Analysis
FCLAX (FCLAX) rose 0.11% to USD 66.63 as of July 26, 2026 at 01:05 UTC, according to Nexqual real-time market data.
FCLAX last closed at USD 66.56; the session ranged USD 66.63–66.63 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 53.36–68.49 (NAS). Source: Nexqual, July 26, 2026 at 01:05 UTC.
Key Statistics (as of July 26, 2026 at 01:05 UTC)
| Price | USD 66.63 |
|---|---|
| Change | ▲ 0.11% (up) |
| Previous Close | USD 66.56 |
| Open | USD 66.63 |
| Day Range | USD 66.63 – 66.63 |
| 52-Week Range | USD 53.36 – 68.49 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FCLAX)
Nexqual's technical model rates FCLAX "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 26, 2026 at 01:05 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.35 (neutral) |
| vs SMA50 | Above (USD 64.87) |
| MACD | 0.21 (positive) |
Financial Health Score (FCLAX)
Nexqual rates FCLAX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 01:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FACDX | Fidelity Advisor Series VII: Fi | USD 61.89 | ▲ 1.26% |
| FMFAX | Fidelity Advisor Materials Fund | USD 97.39 | ▲ 0.4% |
| FDAGX | Fidelity Advisor Consumer Stapl | USD 90.22 | ▼ 0.55% |
| FBTAX | Fidelity Advisor Biotechnology | USD 45.96 | ▲ 0.88% |
| FAFDX | Fidelity Advisor Series VII: Fi | USD 40.72 | ▲ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 01:05 UTC. This page is informational and not investment advice.